arrow
Back
C

Cristina Suárez

harvard university medical affiliates

54H-index
371Paper Count
1.4WCitation Count
Published Papers 115
Publication Date
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Novel pembrolizumab-based treatments as first-line therapy in advanced clear cell renal cell carcinoma: Substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial
err2025-10-18
err0
PREAI
errC. Suarez; C. Rojas; S.J. Shin; P.Yanez Weber; L. Albiges; R. Motzer; H. Hammers; A. Peer; J-L. Lee; W.H. Miller; T. Waddell; V. Neiman; D. Keizman; A.Zwenger Kloster; A. Weickhardt; R. Dziadziuszko; L. Suttner; M. Sharma; J.E. Burgents; T. Powles
errShare
errSave
Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology-based combinations
err2025-10-01
err0
errOAAI
errMcgregor, Bradley A.; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta
errShare
errSave
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study
err2025-10-01
err2
errOAAI
errAlbiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
errShare
errSave
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial
err2025-09-23
err0
errOAAI
errR.J. Motzer; B. Escudier; M. Burotto; T. Powles; A.B. Apolo; M.T. Bourlon; A.Y. Shah; C. Porta; C. Suárez; C.H. Barrios; M. Richardet; H. Gurney; E.R. Kessler; Y. Tomita; J. Bedke; C. Scheffold; M. Askelson; J. Panzica; J. Zhang; M. van Kooten Losio; T.K. Choueiri
errShare
errSave
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study
err2025-09-01
err0
PREAI
errSuarez, Cristina; Torras, Oscar Reig; Barrera, Rafael Morales; Sanchez, Angel Rodriguez; Palacios, Georgia Anguera; Manshino, Andre Miguel Branco; Nunez, Natalia Fernandez; Vidal, Maria Jose Mendez; Carbonero, Iciar Garcia; Calvo, Ovidio Fernandez; Sarrio, Regina Girones; Herrero, Guillermo Crespo; Afonso, Javier Afonso; Fita, Maria Jose Juan; Padro, Josep Guma; Quintela, Martin Lazaro; Rodriguez-Vida, Alejo; Perez, Carolina Hernandez; Colmenero, Ana Medina; Martin, Ricardo Collado; de Espana, Carmen Garcias; Palau, Carmen Molins; Ortega, Esther Martinez; Gallardo, Enrique
errShare
errSave
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial
err2025-07-24
err0
PREAI
errMartin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
errShare
errSave
Corrigendum to “Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients” [Eur. Urol. Oncol. 7 (2024) 954–964]
err2025-05-01
err0
PREAI
errNatalia Jiménez; Marta Garcia de Herreros; Òscar Reig; Mercedes Marín-Aguilera; Caterina Aversa; Laura Ferrer-Mileo; Samuel García-Esteve; Leonardo Rodríguez-Carunchio; Isabel Trias; Albert Font; Alejo Rodriguez-Vida; Miguel Ángel Climent; Sara Cros; Isabel Chirivella; Montserrat Domènech; Mariona Figols; Joan Carles; Cristina Suárez; Daniel Herrero Rivera; Enrique González-Billalabeitia; Claudia Cívico; Núria Sala-González; Vicenç Ruiz de Porras; Maria J. Ribal; Aleix Prat; Begoña Mellado
errShare
errSave
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial
err2025-04-01
err0
errOAAI
errL. Bergmann; L. Albiges; M. Ahrens; M. Gross-Goupil; E. Boleti; G. Gravis; A. Fléchon; M.-O. Grimm; J. Bedke; P. Barthélémy; D. Castellano; B. Mellado; P. Ivanyi; S. Rottey; A. Flörcken; C. Suarez; P. Maroto; V. Grünwald; S.F. Oosting; J. Kopecky; S. Zschäbitz; M. Boegemann; T. Buchler; G. Niegisch; P.J. Goebell; T. Waddell; F. Joly; F. Priou; M. Retz; S. Siemer; U. Zimmermann; D. Deckbar; I. Burkholder; A. Hartmann; J.B. Haanen
errShare
errSave
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma
err2025-02-26
err0
errOAAI
errPal, Sumanta K.; Powles, Thomas; Kanesvaran, Ravindran; Molina-Cerrillo, Javier; Feldman, Darren R.; Barata, Pedro; Liu, Mohan; Bhatt, Aarohi; Wang, Zhong; Nandoskar, Prachi; Suarez, Cristina
errShare
errSave
Conceptual model for facultative symbiosis between sustainable construction and nature-based solutions in the training of engineers in Chile
err2024-12-24
err0
PREAI
errValdes, Hugo; Correa, Christian; Suarez, Cristian; Laurens Arredondo, Luis Alberto; Hurtado Espinosa, Mariela Faviola; Vera-Puerto, Ismael L.; Zagal, Myrna; Arias, Carlos A.
errShare
errSave
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
err2024-12-07
err0
PREAI
errJustine Panian; Caiwei Zhong; Sharon H. Choi; Kristine Ly; Roxanne Quinn; Evan Ferrier; Eddy Saad; Renee Maria Saliby; Carmel Malvar; Sumanta Pal; Hedyeh Ebrahimi; Ben Tran; Evon Jude; Aly-Khan Lalani; Cristina Suarez; Guillermo De Velasco; Ravindran Kanesvaran; Martin Zarba; Elizabeth Liow; Razane El Hajj Chehade; Toni K. Choueiri; Daniel Y.C. Heng; Rana R. McKay
errShare
errSave
Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma
err2024-10-25
err1
errOAAI
errCella, David; Motzer, Robert J.; Suarez, Cristina; Blum, Steven I.; Ejzykowicz, Flavia; Hamilton, Melissa; Wallace, Joel F.; Simsek, Burcin; Zhang, Joshua; Ivanescu, Cristina; Choueiri, Toni K.; Apolo, Andrea B.
errShare
errSave
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
err2024-08-22
err5
PREAI
errChoueiri, T. K.; Powles, T.; Peltola, K.; de Velasco, G.; Burotto, M.; Suarez, C.; Ghatalia, P.; Iacovelli, R.; Lam, E. T.; Verzoni, E.; Gumus, M.; Stadler, W. M.; Kollmannsberger, C.; Melichar, B.; Venugopal, B.; Gross-Goupil, M.; Poprach, A.; De Santis, M.; Schutz, F. A.; Park, S. H.; Nosov, D. A.; Porta, C.; Lee, J. L.; Garcia-del-Muro, X.; Biscaldi, E.; Kopp, R. Manneh; Oya, M.; He, L.; Wang, A.; Perini, R. F.; Vickery, D.; Albiges, L.; Rini, B.
errShare
errSave
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
err2024-08-01
err4
errOAAI
errJimenez, Natalia; de Herreros, Marta Garcia; Reig, Oscar; Marin-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; Garcia-Esteve, Samuel; Rodriguez-Carunchio, Leonardo; Trias, Isabel; Font, Albert; Rodriguez-Vida, Alejo; Climent, Miguel Angel; Cros, Sara; Chirivella, Isabel; Domenech, Montserrat; Figols, Mariona; Carles, Joan; Suarez, Cristina; Rivera, Daniel Herrero; Gonzalez-Billalabeitia, Enrique; Civico, Claudia; Sala-Gonzalez, Nuria; de Porras, Vicenc Ruiz; Ribal, Maria J.; Prat, Aleix; Mellado, Begona
errShare
errSave
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
err2024-08-01
err16
PREAI
errPowles, T.; Albiges, L.; Bex, A.; Comperat, E.; Gruenwald, V.; Kanesvaran, R.; Kitamura, H.; McKay, R.; Porta, C.; Procopio, G.; Schmidinger, M.; Suarez, C.; Teoh, J.; de Velasco, G.; Young, M.; Gillessen, S.
errShare
errSave
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial
err2024-05-01
err18
errOAAI
errPowles, T.; Burotto, M.; Escudier, B.; Apolo, A. B.; Bourlon, M. T.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C. H.; Richardet, M.; Gurney, H.; Kessler, E. R.; Tomita, Y.; Bedke, J.; George, S.; Scheffold, C.; Wang, P.; Fedorov, V.; Motzer, R. J.; Choueiri, T. K.
errShare
errSave
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
errMED
IF11.8
err2023-10-01
err5
errOAAI
errHernando-Calvo, Alberto; Vila-Casadesus, Maria; Bareche, Yacine; Gonzalez-Medina, Alberto; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin, Agatha; Saavedra, Omar; Brana, Irene; Vieito, Maria; Fasani, Roberta; Stagg, John; Mancuso, Francesco; Haibe-Kains, Benjamin; Han, Ming; Berche, Roger; Pugh, Trevor J.; Mirallas, Oriol; Jimenez, Jose; Gonzalez, Nadia Saoudi; Valverde, Claudia; Munoz-Couselo, Eva; Suarez, Cristina; Diez, Marc; Elez, Elena; Capdevila, Jaume; Oaknin, Ana; Saura, Cristina; Macarulla, Teresa; Galceran, Joan Carles; Felip, Enriqueta; Dienstmann, Rodrigo; Bedard, Philippe L.; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; Garralda, Elena; Vivancos, Ana
errShare
errSave
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma
err2023-07-01
err32
errOAAI
errErnst, Matthew S.; Navani, Vishal; Wells, J. Connor; Donskov, Frede; Basappa, Naveen; Labaki, Chris; Pal, Sumanta K.; Meza, Luis; Wood, Lori A.; Ernst, D. Scott; Szabados, Bernadett; McKay, Rana R.; Parnis, Francis; Suarez, Cristina; Yuasa, Takeshi; Lalani, Aly-Khan; Alva, Ajjai; Bjarnason, Georg A.; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
errLANCET
IF88.5
err2023-07-01
err74
errOAAI
errPal, Sumanta Kumar; Albiges, Laurence; Tomczak, Piotr; Suarez, Cristina; Voss, Martin H.; de Velasco, Guillermo; Chahoud, Jad; Mochalova, Anastasia; Procopio, Giuseppe; Mahammedi, Hakim; Zengerling, Friedemann; Kim, Chan; Osawa, Takahiro; Angel, Martin; Gupta, Suyasha; Khan, Omara; Bergthold, Guillaume; Liu, Bo; Kalaitzidou, Melania; Huseni, Mahrukh; Scheffold, Christian; Powles, Thomas; Choueiri, Toni K.
errShare
errSave